VMP 42296511000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Montelukast 4mg granules sachets sugar free
BNF code 0303020G0AAADAD
Virtual Therapeutic Moiety Montelukast
Date identifier became valid 29 Sep 2023
Previous product identifier 410944008
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 1 Sep 2007
Previous name Montelukast 4mg granules sachets
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units sachet
Unit dose unit of measure sachet
Virtual Product Ingredient
Ingredient Montelukast sodium
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 373728005
Strength value numerator 4.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route granules.oral
Dose Form
Formulation Oral granules
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Montelukast 4mg granules sachets sugar free (A A H Pharmaceuticals Ltd)
Montelukast 4mg granules sachets sugar free (Alliance Healthcare (Distribution) Ltd)
Montelukast 4mg granules sachets sugar free (Almus Pharmaceuticals Ltd)
Montelukast 4mg granules sachets sugar free (Teva UK Ltd)
Montelukast 4mg granules sachets sugar free (Torrent Pharma (UK) Ltd)
Singulair Paediatric 4mg granules sachets (CST Pharma Ltd)
Singulair Paediatric 4mg granules sachets (Organon Pharma (UK) Ltd)
Virtual Medicinal Product Packs
Montelukast 4mg granules sachets sugar free 28 sachet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback